EA200400384A1 - SOLUBLE T-CELL RECEPTOR - Google Patents
SOLUBLE T-CELL RECEPTORInfo
- Publication number
- EA200400384A1 EA200400384A1 EA200400384A EA200400384A EA200400384A1 EA 200400384 A1 EA200400384 A1 EA 200400384A1 EA 200400384 A EA200400384 A EA 200400384A EA 200400384 A EA200400384 A EA 200400384A EA 200400384 A1 EA200400384 A1 EA 200400384A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- soluble
- tcr
- chain
- cell receptor
- domain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Abstract
Настоящее изобретение обеспечивает получение растворимого Т-лимфоцитного рецептора (soluble T cell receptor, sTCR), который содержит (I) всю α-цепь TCR или ее часть за исключением ее трансмембранного домена и (II) всю β-цепь TCR или ее часть за исключением ее трансмембранного домена. При этом каждый из компонентов (I) и (II) содержит функциональный вариабельный домен и по меньшей мере часть константного домена цепи TCR, и оба они соединены дисульфидной связью, расположенной между остатками аминокислот константных доменов и отсутствующей в нативном TCR.Отчет о международном поиске был опубликован 2003.05.22.The present invention provides a soluble T-lymphocyte receptor (soluble T cell receptor, sTCR), which contains (I) the entire TCR α-chain or part thereof except its transmembrane domain and (II) the entire TCR β-chain or part thereof its transmembrane domain. In addition, each of components (I) and (II) contains a functional variable domain and at least part of the constant domain of the TCR chain, and both are linked by a disulfide bond located between the amino acid residues of the constant domains and not in the native TCR. published 2003.05.22.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0121187A GB0121187D0 (en) | 2001-08-31 | 2001-08-31 | Substances |
US40418202P | 2002-08-16 | 2002-08-16 | |
GB0219146A GB0219146D0 (en) | 2002-08-16 | 2002-08-16 | Substances |
PCT/GB2002/003986 WO2003020763A2 (en) | 2001-08-31 | 2002-08-30 | Soluble t cell receptor |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200400384A1 true EA200400384A1 (en) | 2004-08-26 |
EA006601B1 EA006601B1 (en) | 2006-02-24 |
Family
ID=47682092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400384A EA006601B1 (en) | 2001-08-31 | 2002-08-30 | Soluble t cell receptor |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100945977B1 (en) |
EA (1) | EA006601B1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080840A (en) | 1992-01-17 | 2000-06-27 | Slanetz; Alfred E. | Soluble T cell receptors |
-
2002
- 2002-08-30 EA EA200400384A patent/EA006601B1/en not_active IP Right Cessation
- 2002-08-30 KR KR1020047003158A patent/KR100945977B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR100945977B1 (en) | 2010-03-09 |
KR20040039322A (en) | 2004-05-10 |
EA006601B1 (en) | 2006-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE290020T1 (en) | SOLUBLE T CELL RECEPTOR | |
ATE388964T1 (en) | MODIFIED SOLUBLE T-CELL RECEPTOR | |
PT1133559E (en) | PROTEIN ACOPLATE RECEPTOR G ORFAO HUMAN, RUP3 | |
HUS1600019I1 (en) | Compositions comprising polypeptides | |
DK1124568T3 (en) | Polyspecific Binding Molecules and Uses thereof | |
DE69730693D1 (en) | MHC COMPLEXES AND THEIR USE | |
ATE348106T1 (en) | PEPTIDE ANALOGS DERIVED FROM THE TUMOR NECROSIS FACTOR RECEPTOR | |
DK0726952T3 (en) | Receptor called ACT-4 on the surface of activated T cells | |
ATE533784T1 (en) | SOLUBLE, SINGLE-CHAIN T-CELL RECEPTOR PROTEINS | |
DK1047781T3 (en) | IL-18 receptors | |
DK1129186T3 (en) | A factor VIII polypeptide having factor VIII: C activity | |
EA199800376A1 (en) | Antagonists of receptors of excitatory amino acid | |
ES2129120T3 (en) | A RECEPTOR OF HUMAN T CELLS FROM THE FAMILY OF RECEPTORS COUPLED TO PROTEIN G. | |
TR199801027T2 (en) | Method for diagnosis and treatment of epithelioma. | |
EA200400384A1 (en) | SOLUBLE T-CELL RECEPTOR | |
ATE174344T1 (en) | CHIMERIC SELECTINS AVAILABLE THROUGH DOMAIN EXCHANGE AND THEIR USES | |
ATE466880T1 (en) | CYTOKINE POLYPEPTIDE VARIANTS | |
CY1107740T1 (en) | HUMAN ORPHANE CONNECTED TO G PROTEIN RUP3 RECEPTOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
PC4A | Registration of transfer of a eurasian patent by assignment | ||
TC4A | Change in name of a patent proprietor in a eurasian patent |
Designated state(s): AM AZ KZ KG MD TJ TM |
|
PC4A | Registration of transfer of a eurasian patent by assignment |